• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Life Science Equipment

Myriad Genetics Inc

+ Add to Watchlist

MYGN:US

37.0200 USD 0.3300 0.88%

As of 20:10:00 ET on 07/25/2014.

Snapshot for Myriad Genetics Inc (MYGN)

Open: 37.2600 Day's Range: 36.8000 - 37.7000 Volume: 509,399
Previous Close: 37.3500 52wk Range: 20.0200 - 42.5000 1-Yr Rtn: +17.86%

Stock Chart for MYGN

No chart data available.
  • MYGN:US 37.0300
  • 1D
  • 1M
  • 1Y
37.3500
Interactive MYGN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MYGN

Current P/E Ratio (ttm) 15.4895
Estimated P/E(06/2014) 15.4508
Relative P/E vs. SPX 0.8561
Earnings Per Share (USD) (ttm) 2.3900
Est. EPS (USD) (06/2014) 2.3960
Est. PEG Ratio 0.9775
Market Cap (M USD) 2,769.98
Shares Outstanding (M) 74.82
30 Day Average Volume 847,166
Price/Book (mrq) 3.8193
Price/Sale (ttm) 3.7347
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MYGN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MYGN

Myriad Genetics, Inc. develops and markets molecular diagnostic products to provide physicians with information to help guide the care of their patients, to prevent disease, delay the onset of disease, or catch disease at an early stage.

Peter D MeldrumPresident/CEO/Co-FounderJames S Evans "Jim"CFO/Treasurer
Robert Gardner HarrisonChief Information OfficerJerry S LanchburyChief Scientific Officer
More Company Profile & Key Executives for MYGN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil